ARDELYX, INC.·4

Jun 17, 4:01 PM ET

RAAB MICHAEL 4

4 · ARDELYX, INC. · Filed Jun 17, 2026

Research Summary

AI-generated summary of this filing

Updated

Ardelyx (ARDX) CEO Michael Raab Sells 41,666 Shares, Exercises Options

What Happened

  • Michael Raab, President & CEO and Director of Ardelyx (ARDX), executed same-day option activity and an open-market sale on June 15, 2026. The filing reports he exercised 20,833 option-derived shares at $0.99 (cost ~$20,625), a separate M-coded disposition of 20,833 shares at $0.00, and sold 41,666 shares in the open market for aggregate proceeds of about $236,346 (weighted average sale price $5.67).

Key Details

  • Transaction date: June 15, 2026; Form 4 filed June 17, 2026 (appears timely).
  • Open-market sale: 41,666 shares at a weighted average price of $5.67; sale prices ranged $5.625–$5.77 (filing offers to provide breakdown on request). Total proceeds ≈ $236,346.
  • Option exercise (M): 20,833 shares acquired at $0.99 (cash paid ≈ $20,625).
  • M-coded disposition: 20,833 shares reported disposed at $0.00 (filing does not give further detail on the nature of this disposition).
  • Ownership after transaction: Not specified in the provided filing excerpt.
  • Notable footnotes: Trades were made pursuant to a 10b5-1 trading plan adopted Nov 7, 2025 (F1). Shares are held in family trusts (F3, F4). The exercised option vests monthly over 48 months starting Jan 6, 2022 (F5). Exhibit 24.1 (Power of Attorney) attached.

Context

  • The filing shows both an exercise and a same-day zero-dollar disposition of an equal number of shares plus an open-market sale. This pattern often reflects net settlement or withholding related to option exercises, but the filing itself does not detail the mechanics—only the reported transactions and footnotes. The sale was executed under a 10b5-1 plan, which generally means the trades were pre-authorized.

Insider Transaction Report

Form 4
Period: 2026-06-15
RAAB MICHAEL
DirectorPresident & CEO
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-06-15$0.99/sh+20,833$20,6251,740,866 total
  • Sale

    Common Stock

    [F1][F2]
    2026-06-15$5.67/sh41,666$236,3461,699,200 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F1][F5]
    2026-06-1520,833311,668 total
    Exercise: $0.99Exp: 2032-01-06Common Stock (20,833 underlying)
Holdings
  • Common Stock

    [F3]
    (indirect: By Trust)
    24,364
  • Common Stock

    [F4]
    (indirect: By Trust)
    1,000
Footnotes (5)
  • [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025.
  • [F2]Transaction was executed in multiple trades in prices ranging from $5.625 to $5.77, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  • [F3]The shares are directly held by Michael G. Raab, Trustee of the Michael G. Raab Living Trust dated July 25, 2012.
  • [F4]The shares are owned directly by trusts for the benefit of the Reporting Person's children.
  • [F5]The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
Signature
/s/ Felecia Ettenberg, Attorney-in-Fact for Michael Raab|2026-06-17

Documents

4 files
  • 4
    wk-form4_1781726515.xmlPrimary

    FORM 4

  • EX-24
  • GRAPHIC
    ardelyx-section16powerof001.jpg
  • GRAPHIC
    ardelyx-section16powerof002.jpg